"Misoprostol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic analog of natural prostaglandin E1. It produces a dose-related inhibition of gastric acid and pepsin secretion, and enhances mucosal resistance to injury. It is an effective anti-ulcer agent and also has oxytocic properties.
Descriptor ID |
D016595
|
MeSH Number(s) |
D10.251.355.255.550.775.450.500 D23.469.050.175.725.775.450.500 D23.469.700.660.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Misoprostol".
Below are MeSH descriptors whose meaning is more specific than "Misoprostol".
This graph shows the total number of publications written about "Misoprostol" by people in this website by year, and whether "Misoprostol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 0 | 1 |
2017 | 6 | 2 | 8 |
2018 | 4 | 0 | 4 |
2019 | 5 | 0 | 5 |
2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Misoprostol" by people in Profiles.
-
Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study. Contraception. 2022 03; 107:23-28.
-
Women's experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic: a qualitative evaluation. BJOG. 2021 10; 128(11):1752-1761.
-
Provision of medication abortion in Hawai'i during COVID-19: Practical experience with multiple care delivery models. Contraception. 2021 07; 104(1):49-53.
-
Expansion of a direct-to-patient telemedicine abortion service in the United States and experience during the COVID-19 pandemic. Contraception. 2021 07; 104(1):43-48.
-
Preventing post-partum haemorrhage at home during COVID-19: what are we waiting for? Lancet Glob Health. 2021 03; 9(3):e245-e246.
-
Deaths and Severe Adverse Events after the use of Mifepristone as an Abortifacient from September 2000 to February 2019. Issues Law Med. 2021; 36(1):3-26.
-
Misoprostol in the era of COVID-19: a love letter to the original medical abortion pill. Sex Reprod Health Matters. 2020 12; 28(1):1829406.
-
Options for Teens with No Options: A Self-Managed Second Trimester Abortion. J Pediatr Adolesc Gynecol. 2021 Apr; 34(2):226-227.
-
Commentary: No-test medication abortion: A sample protocol for increasing access during a pandemic and beyond. Contraception. 2020 06; 101(6):361-366.
-
Management of first-trimester miscarriage: a systematic review and network meta-analysis. Hum Reprod Update. 2019 05 01; 25(3):362-374.